新冠疫情中的毛霉菌病：锌在印度是隐形杀手吗？
Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?
作者信息
Nath Sayan, Baidya Dalim K
机构信息
Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, Delhi, India.
出版信息
Indian J Crit Care Med. 2021 Sep;25(9):1079-1080. doi: 10.5005/jp-journals-10071-23938.
Abstract
Nath S, Baidya DK. Mucormycosis in COVID-19: Is Zinc a Silent Killer in India? Indian J Crit Care Med 2021;25(9):1079-1080.
摘要
纳特 S、拜迪亚 DK。新冠肺炎中的毛霉病：锌在印度是隐形杀手吗？《印度重症监护医学杂志》2021 年；25(9):1079 - 1080。
相似文献
1
Mucormycosis in COVID-19: Is Zinc a Silent Killer in India?新冠疫情中的毛霉菌病：锌在印度是隐形杀手吗？
Indian J Crit Care Med. 2021 Sep;25(9):1079-1080. doi: 10.5005/jp-journals-10071-23938.
2
Aftermath of COVID-19 and Critical Care in India.印度的新冠疫情后果与重症护理
Indian J Crit Care Med. 2021 Oct;25(10):1173-1175. doi: 10.5005/jp-journals-10071-23987.
3
A Proposal for Dedicated "Prone Team" and "Prone Bundle of Care" in COVID-19 ICU.关于在新冠病毒感染重症监护病房设立专门“俯卧位团队”和“俯卧位护理包”的提议
Indian J Crit Care Med. 2021 Mar;25(3):349-350. doi: 10.5005/jp-journals-10071-23754.
4
Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report.一名重症 COVID-19 肺炎患者的皮肤毛霉病：一份极其罕见的病例报告。
Indian J Crit Care Med. 2021 Nov;25(11):1318-1319. doi: 10.5005/jp-journals-10071-24026.
5
Point-of-care Glucose Monitoring in COVID-19 Intensive Care Unit: How's It Different?新冠重症监护病房中的即时血糖监测：有何不同？
Indian J Crit Care Med. 2021 Dec;25(12):1465-1466. doi: 10.5005/jp-journals-10071-24037.
6
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Predictors of the Early Requirement of Mechanical Ventilation in COVID-19 Patients.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为新型冠状病毒肺炎患者早期机械通气需求的预测指标
Indian J Crit Care Med. 2020 Nov;24(11):1143-1144. doi: 10.5005/jp-journals-10071-23663.
7
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: Is Sequela the Bigger Threat?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行：后遗症是更大的威胁吗？
Indian J Crit Care Med. 2021 Feb;25(2):245-246. doi: 10.5005/jp-journals-10071-23734.
8
Ten Practice Changes in COVID-19 Intensive Care Unit of a Tertiary Care Teaching Hospital in India during the Peak of Pandemic: Adapt and Improve.印度一家三级护理教学医院在疫情高峰期新冠重症监护病房的十项实践变革：适应与改进
Indian J Crit Care Med. 2022 Jun;26(6):710-711. doi: 10.5005/jp-journals-10071-24227.
9
Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance.泊沙康唑预防新型冠状病毒肺炎相关毛霉菌病：抗真菌耐药性增加的一个令人担忧的因素
Indian J Crit Care Med. 2021 Oct;25(10):1209-1210. doi: 10.5005/jp-journals-10071-23981.
10
SARS-CoV-2 Infection Presenting with Hyperglycemia and Ketosis: A Case Series of Three Diabetic Patients.新型冠状病毒肺炎合并高血糖和酮症：3例糖尿病患者的病例系列
Indian J Crit Care Med. 2020 Nov;24(11):1141-1142. doi: 10.5005/jp-journals-10071-23595.
引用本文的文献
1
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.2019冠状病毒病相关毛霉病的当前治疗选择：现状与未来展望
J Clin Med. 2022 Jun 23;11(13):3620. doi: 10.3390/jcm11133620.
2
Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents.开发用于防治 COVID-19 的治疗和预防锌组合物：趋势、发明和专利的一瞥。
Nutrients. 2022 Mar 14;14(6):1227. doi: 10.3390/nu14061227.
3
Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc.失代偿期肝硬化的白蛋白替代治疗：别忘记锌。
Nutrients. 2021 Nov 10;13(11):4011. doi: 10.3390/nu13114011.
本文引用的文献
1
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
2
Epidemiology of Mucormycosis in India.印度毛霉菌病的流行病学
Microorganisms. 2021 Mar 4;9(3):523. doi: 10.3390/microorganisms9030523.
3
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.高剂量锌和抗坏血酸补充剂与常规治疗相比对 SARS-CoV-2 感染门诊患者症状持续时间和缓解的影响：COVID A to Z 随机临床试验。
JAMA Netw Open. 2021 Feb 1;4(2):e210369. doi: 10.1001/jamanetworkopen.2021.0369.
4
Invasive fungal diseases during COVID-19: We should be prepared.2019冠状病毒病期间的侵袭性真菌病：我们应做好准备。
J Mycol Med. 2020 Jun;30(2):100971. doi: 10.1016/j.mycmed.2020.100971. Epub 2020 Apr 6.
5
Activity of Combinations of Zinc Chelators with Amphotericin B and Posaconazole against Six Mucorales Species.锌螯合剂与两性霉素 B 和泊沙康唑联合对 6 种毛霉目真菌的活性。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00266-19. Print 2019 May.
6
Novel Zinc-Attenuating Compounds as Potent Broad-Spectrum Antifungal Agents with and Efficacy.新型锌减弱化合物作为强效广谱抗真菌剂，具有 和 功效。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02024-17. Print 2018 May.
7
An evolutionary perspective on zinc uptake by human fungal pathogens.人类真菌病原体锌摄取的进化视角。
Metallomics. 2015 Jun;7(6):979-85. doi: 10.1039/c4mt00331d.
8
Fungal zinc metabolism and its connections to virulence.真菌的锌代谢及其与毒力的关系。
Front Cell Infect Microbiol. 2013 Oct 14;3:65. doi: 10.3389/fcimb.2013.00065. eCollection 2013.
9
Fungal susceptibility to zinc deprivation.真菌对锌缺乏的敏感性。
J Lab Clin Med. 2004 Oct;144(4):208-14. doi: 10.1016/j.lab.2004.07.007.
Zotero 插件